Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.463 USD | -1.68% | -5.96% | -48.40% |
Feb. 07 | Transcript : 23andMe Holding Co., Q3 2024 Earnings Call, Feb 07, 2024 | |
Feb. 07 | Earnings Flash (ME) 23ANDME Reports Q3 Revenue $44.7M, vs. Street Est of $56.3M | MT |
Chart calendar 23andMe Holding Co.
Upcoming events on 23andMe Holding Co.
Past events on 23andMe Holding Co.
2024-03-05 09:50 am | TD Cowen Health Care Conference |
2024-02-07 04:30 pm | Q3 2024 Earnings Call |
2024-02-07 04:01 pm | Q3 2024 Earnings Release |
2023-11-08 04:30 pm | Q2 2024 Earnings Call |
2023-11-08 04:05 pm | Q2 2024 Earnings Release |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number: 619 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number: 609 |
2023-09-06 11:30 am | Annual General Meeting |
2023-08-08 04:30 pm | Q1 2024 Earnings Call |
2023-08-08 04:05 pm | Q1 2024 Earnings Release |
2023-05-25 04:30 pm | Q4 2023 Earnings Call |
2023-05-24 | Q4 2023 Earnings Release After hours |
2023-04-18 09:00 am | American Association for Cancer Research Meeting - Abstract Number: CT174 |
2023-03-08 11:10 am | Cowen Health Care Conference |
2023-03-01 09:30 am | Citi Healthcare Services Medtech Tools & HCIT Conference |
2023-02-08 04:30 pm | Q3 2023 Earnings Call |
2023-02-08 04:05 pm | Q3 2023 Earnings Release |
2022-12-01 11:20 am | Evercore ISI HEALTHCONx Conference |
2022-11-30 09:06 am | Piper Sandler Healthcare Conference |
2022-11-29 12:00 am | Evercore ISI HealthCONx Conference |
Annual results
Fiscal Period | March | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 272 275 -1.28% | 299 298 0.36% | 217 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -151 -207 27.34% | -161 -248 34.99% | 326 |
EBIT Million USD | Released Forecast Spread | 0,00 | -268 -231 -15.8% | -314 -288 -9.11% | -548 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -221 -250 11.61% | -314 -319 1.28% | 0,00 |
Net income Million USD | Released Forecast Spread | -184 | -217 -250 12.83% | -312 -317 1.69% | 0,00 |
EPS USD | Released Forecast Spread | -4,23 | -0,60 -0,70 14.29% | -0,69 -0,75 8% | -1,10 |
Announcement Date | 21/06/21 | 26/05/22 | 25/05/23 | - |
Quarterly results
Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 56,9 54,3 4.77% | 101 103 -2.17% | 64,5 61,6 4.73% | 75,7 63,5 19.07% | 66,9 65,9 1.59% | 92,4 88,4 4.5% | 60,9 56,9 6.97% | 50,0 56,8 -11.97% | 44,7 56,3 -20.52% | 61,4 | 63,8 | 64,9 | 61,6 |
EBITDA Million USD | Released Forecast Spread | -29,7 -48,6 38.98% | -43,3 -58,8 26.41% | -65,0 | -64,4 | -25,4 | -28,2 | |||||||
EBIT Million USD | Released Forecast Spread | -96,7 -59,7 -61.95% | -59,3 -69,1 14.18% | -89,6 -76,4 -17.23% | -68,0 -86,8 21.64% | -97,1 -94,5 -2.72% | -69,3 -77,3 10.42% | -78,7 | -103 | -65,0 | -68,5 | |||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -67,3 -89,7 24.93% | -92,6 -94,6 2.14% | |||||||||||
Net income Million USD | Released Forecast Spread | -66,1 -89,5 26.18% | -92,0 -93,3 1.44% | |||||||||||
EPS USD | Released Forecast Spread | -0,21 -0,15 -40% | -0,16 -0,15 -6.67% | -0,20 -0,17 -17.65% | -0,15 -0,20 23.08% | -0,20 -0,21 4.76% | -0,14 -0,18 22.22% | -0,23 -0,19 -21.05% | -0,16 -0,17 5.88% | |||||
Announcement Date | 10/02/22 | 26/05/22 | 08/08/22 | 07/11/22 | 08/02/23 | 25/05/23 | 08/08/23 | 08/11/23 | 07/02/24 | - | - | - | - |
Past sector events for 23andMe Holding Co.
2024-03-06 | FLEURY S.A.: Q4 2023 Earnings Release |
2024-02-29 04:10 pm | RADNET, INC.: Q4 2023 Earnings Release |
2024-02-28 07:00 am | FULGENT GENETICS, INC.: Q4 2023 Earnings Release |
2024-02-27 04:05 pm | OPKO HEALTH, INC.: Q4 2023 Earnings Release |
2024-02-26 05:19 pm | HEALIUS LIMITED: Q2 2024 Earnings Release |
2024-02-20 05:20 pm | HEALIUS LIMITED: Q2 2024 Sales and Revenue Release - Trading Update |
2024-02-20 04:05 pm | NEOGENOMICS, INC.: Q4 2023 Earnings Release |
2024-02-19 04:55 pm | SONIC HEALTHCARE LIMITED: Q2 2024 Earnings Release |
2024-02-08 | BML, INC.: Q3 2023 Earnings Release |
2024-02-08 | H.U. GROUP HOLDINGS, INC.: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock 23andMe Holding Co. - Nasdaq
- Calendar 23andMe Holding Co.